The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Eastman Chemical's revenues will increase 30.5% and EPS will grow 67.6%.
The average estimate for revenue is $2.25 billion. On the bottom line, the average EPS estimate is $1.19.
Last quarter, Eastman Chemical tallied revenue of $2.26 billion. GAAP reported sales were 25% higher than the prior-year quarter's $1.81 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.57. GAAP EPS of $0.99 for Q3 were 19% lower than the prior-year quarter's $1.22 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 26.6%, 270 basis points better than the prior-year quarter. Operating margin was 17.6%, 200 basis points better than the prior-year quarter. Net margin was 6.8%, 280 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $8.18 billion. The average EPS estimate is $5.38.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 189 members out of 215 rating the stock outperform, and 26 members rating it underperform. Among 68 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 64 give Eastman Chemical a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Eastman Chemical is outperform, with an average price target of $60.57.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Eastman Chemical to My Watchlist.